News on Capital Genomix from BioPortfolio.com http://www.BioPortfolio.com Consolidated Capital Genomix news from BioPortfolio.com Wed, 10 Feb 2010 03:43:12 GMT en Osta Biotechnologies Announces $2.5 Million Private Placement Led by Sherbrooke Street Capitalhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038920&HITNO=0&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Capital%20Genomix&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038920&THISHREF=http://c.moreover.com/click/here.pl%3fz2537837328%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038920&HITNO=0&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Capital%20Genomix&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038920&THISHREF=http://c.moreover.com/click/here.pl%3fz2537837328%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Canada: BASF Venture Capital invests in Canadian company Quantiam Technologies Inchttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032837&HITNO=1&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Capital%20Genomix&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032837&THISHREF=http://c.moreover.com/click/here.pl%3fz2534832334%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032837&HITNO=1&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Capital%20Genomix&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032837&THISHREF=http://c.moreover.com/click/here.pl%3fz2534832334%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comChemie.de: Reliance Capital drops metal, pharma; picks bankinghttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038147&HITNO=2&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Capital%20Genomix&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038147&THISHREF=http://c.moreover.com/click/here.pl%3fz2537499288%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038147&HITNO=2&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Capital%20Genomix&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038147&THISHREF=http://c.moreover.com/click/here.pl%3fz2537499288%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMoneycontrol.com: Chesstown Capital Inc. (TSXV: CHC.P) Announces the Signing of a Non-Binding Letter of Intent for Its Proposedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036614&HITNO=3&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Capital%20Genomix&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036614&THISHREF=http://c.moreover.com/click/here.pl%3fz2536684579%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036614&HITNO=3&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Capital%20Genomix&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036614&THISHREF=http://c.moreover.com/click/here.pl%3fz2536684579%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGenetic Engineering News: Mercks Price Target, Estimates Raised at Barclays Capital (MRK)http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035807&HITNO=4&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Capital%20Genomix&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035807&THISHREF=http://c.moreover.com/click/here.pl%3fz2536382332%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035807&HITNO=4&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Capital%20Genomix&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035807&THISHREF=http://c.moreover.com/click/here.pl%3fz2536382332%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNasdaq: Financings roundup: PatientSafe raises $30M in 'B-1' round led by TPGhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034507&HITNO=5&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Capital%20Genomix&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034507&THISHREF=http://c.moreover.com/click/here.pl%3fz2535828340%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034507&HITNO=5&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Capital%20Genomix&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034507&THISHREF=http://c.moreover.com/click/here.pl%3fz2535828340%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMedical Device Daily: Osta Biotechnologies Announces $2.5 Million Private Placement Led by Sherbrooke Street Capitalhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038539&HITNO=6&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Capital%20Genomix&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038539&THISHREF=http://c.moreover.com/click/here.pl%3fz2537649628%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038539&HITNO=6&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Capital%20Genomix&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038539&THISHREF=http://c.moreover.com/click/here.pl%3fz2537649628%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNewsBlaze: Biogen Idec, Inc. Q4 2009 Earnings Call Transcripthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038461&HITNO=7&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Capital%20Genomix&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038461&THISHREF=http://c.moreover.com/click/here.pl%3fz2537619979%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038461&HITNO=7&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Capital%20Genomix&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038461&THISHREF=http://c.moreover.com/click/here.pl%3fz2537619979%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSeeking Alpha: Osta Biotechnologies arranges $2.5-million placementhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038371&HITNO=8&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Capital%20Genomix&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038371&THISHREF=http://c.moreover.com/click/here.pl%3fz2537583645%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038371&HITNO=8&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Capital%20Genomix&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038371&THISHREF=http://c.moreover.com/click/here.pl%3fz2537583645%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comStockwatch: Osta Biotechnologies Announces $2.5 Million Private Placement Led by Sherbrooke Street Capitalhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038296&HITNO=9&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Capital%20Genomix&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038296&THISHREF=http://c.moreover.com/click/here.pl%3fz2537558273%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038296&HITNO=9&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Capital%20Genomix&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038296&THISHREF=http://c.moreover.com/click/here.pl%3fz2537558273%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMarket Wire: Consortium of investors sells TOPIGEN Pharmaceuticals to Pharmaxishttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037691&HITNO=10&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Capital%20Genomix&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037691&THISHREF=http://c.moreover.com/click/here.pl%3fz2537243001%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037691&HITNO=10&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Capital%20Genomix&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037691&THISHREF=http://c.moreover.com/click/here.pl%3fz2537243001%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comIndividual.com: Nexamp Secures $6.5 Million in Venture Financing from Leading Renewable Energy and IT Investorshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035401&HITNO=11&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Capital%20Genomix&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035401&THISHREF=http://c.moreover.com/click/here.pl%3fz2536227566%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035401&HITNO=11&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Capital%20Genomix&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035401&THISHREF=http://c.moreover.com/click/here.pl%3fz2536227566%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFreshnews.com: Roth Capital Upgrades BioMarin Pharmaceutical (BMRN) to Buyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034633&HITNO=12&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Capital%20Genomix&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034633&THISHREF=http://c.moreover.com/click/here.pl%3fz2535897750%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034633&HITNO=12&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Capital%20Genomix&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034633&THISHREF=http://c.moreover.com/click/here.pl%3fz2535897750%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comStreet Insider: Mayfield Fund and First Round Capital Host Entrepreneur Networking Eventhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034343&HITNO=13&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Capital%20Genomix&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034343&THISHREF=http://c.moreover.com/click/here.pl%3fz2535723141%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034343&HITNO=13&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Capital%20Genomix&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034343&THISHREF=http://c.moreover.com/click/here.pl%3fz2535723141%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Canada: EpiCept Establishes At-the-Market Public Stock Offering Programhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032853&HITNO=14&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Capital%20Genomix&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032853&THISHREF=http://c.moreover.com/click/here.pl%3fz2534835616%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032853&HITNO=14&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Capital%20Genomix&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032853&THISHREF=http://c.moreover.com/click/here.pl%3fz2534835616%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: